Zu "693228-63-6" wurden 4 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
CYC-116
Artikelnummer: Cay21205-5
CYC-116 is a potent Aurora kinase inhibitor exhibiting Ki values of 8.0 and 9.2 nM for Aurora kinases A and B, respectively. It is significantly less potent against a panel of cyclin-dependent kinases and other related kinases, with the exception of Flt-3 (Ki = 44 nM). CYC-116 exhibits broad-spectrum...
| Schlagworte: | 4-(2-amino-4-methyl-5-thiazolyl)-N-[4-(4-morpholinyl)phenyl]-2-pyrimidinamine |
| Anwendung: | Aurora / VEGFR2 inhibitor |
| CAS | 693228-63-6 |
| MW: | 368.5 D |
ab 51,00 €
CYC-116
Artikelnummer: LKT-C9708.25
CYC-116 inhibits aurora kinases B and C (AurB, AurC), preventing mitotic spindle formation and proper completion of mitosis. This compound exhibits anticancer chemotherapeutic activity and is currently in clinical trials. CYC-116 inhibits proliferation in a variety of in vitro cancer models.
| Anwendung: | Aurora kinase B / C inhibitor |
| CAS | 693228-63-6 |
| MW: | 368.46 D |
ab 164,00 €
CYC116
Artikelnummer: SYN-1034-M001
Soluble in DMSO or ethanol. CYC116 is an orally active small molecule multi-kinase inhibitor with anti-neoplastic activity. CYC116 inhibits Aurora kinases A/B and vascular endothelial growth factor receptor 2 (VEGFR2), resulting in disruption of the cell cycle, rapid cell death, and the inhibition of angiogenesis....
| Schlagworte: | CYC-116 |
| Anwendung: | Aurora A / B inhibitor |
| CAS | 693228-63-6 |
| MW: | 368,5 D |
ab 92,00 €
CYC-116
Artikelnummer: TGM-T6458-100mg
Description: CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM, is less potent to VEGFR2 (Ki of 44 nM), with 50-fold greater potency than CDKs, not active against PKA, Akt/PKB, PKC, no effect on GSK-3alpha/beta, CK2, Plk1 and SAPK2A. Phase 1. Target: FLT, CDK, Aurora Kinase, VEGFR, S6 Kinase....
| Anwendung: | Aurora / VEGFR2 inhibitor |
| CAS | 693228-63-6 |
| MW: | 368.46 D |
ab 32,00 €
